Abstract
Objective. To analyze the influence of IL6R rs8192284 polymorphism on the disease activity of rheumatoid arthritis (RA). Methods. Patients with RA (n = 281) were followed for a median of 4.2 years. A total of 1143 disease activity measurements using the 28-joint count Disease Activity Score (DAS28) were performed. A mixed-effect model was used to analyze the measurements. Results. A statistically significant interaction was observed between IL6R rs8192284 polymorphism and the presence of anticyclic citrullinated peptide (anti-CCP) antibodies (p = 0.008). An inverse relationship between the polymorphism and DAS28 was observed depending on anti-CCP status. Conclusion. The anti-CCP status in patients with RA determines the association between the IL6R rs8192284 polymorphism and disease activity. The Journal of Rheumatology Copyright © 2010. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Lamas, J. R., Rodríguez-Rodríguez, L., Varadé, J., López-Romero, P., Tornero-Esteban, P., Abasolo, L., … Fernández-Gutiérrez, B. (2010). Influence of IL6R rs8192284 polymorphism status in disease activity in rheumatoid arthritis. Journal of Rheumatology, 37(8), 1579–1581. https://doi.org/10.3899/jrheum.091455
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.